Preparedness of China's health care system to provide access to a disease-modifying Alzheimer's treatment.
Soeren MattkeWei Kok LohKah-Hung YuenJoanne YoongPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2023)
Closing this gap will require the introduction of high-performing blood tests, greater reliance on cerebrospinal fluid (CSF) testing, and expansion of positron emission tomography (PET) capacity.